269 studies found for:    Open Studies | "Parasitic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
22 Recruiting Taenia Solium Control Case Study in Zambia
Conditions: Cysticercosis;   Helminthiasis
Intervention: Behavioral: CLTS
23 Unknown  Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients
Condition: Neurocysticercosis
Interventions: Drug: Albendazole;   Drug: Dexamethasone;   Drug: Omeprazole
24 Recruiting People Presenting With Neurocysticercosis in North America
Condition: Neurocysticercosis
Intervention:
25 Recruiting Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT
Condition: Neurocysticercosis
Interventions: Drug: 7 days of albendazole  15 mg/kg/day;   Drug: 28 days of albendazole 15 mg/kg/day
26 Unknown  Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
Conditions: Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: Peginterferon Alfa-2a plus Ribavirin
27 Unknown  Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria
Condition: Malaria
Intervention: Drug: Fosmidomycin and clindamycin
28 Not yet recruiting A Prospective, Phase II Clinical Trial for Evaluation of G- CSF (Colony Stimulating Factor) in Patients With Chronic Chagas Cardiomyopathy
Condition: Chronic Chagasic Myocarditis
Interventions: Drug: Treatment with G-CSF (Granulocyte colony stimulating factor);   Drug: Placebo saline
29 Unknown  Malarial Immunity in Pregnant Cameroonian Women
Condition: Plasmodium Falciparum Malaria
Intervention:
30 Recruiting Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)
Condition: Chagas Disease With Heart Failure
Intervention: Drug: Aspirin
31 Not yet recruiting Safety and Efficacy of Primaquine for P. Vivax
Condition: Malaria
Interventions: Drug: Primaquine;   Drug: delayed primaquine
32 Not yet recruiting Miltefosine for Children With PKDL
Condition: Post Kala Azar Dermal Leishmaniasis
Intervention: Drug: Miltefosine
33 Recruiting Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
Conditions: Soil-transmitted Helminthiasis;   Schistosomiasis;   Strongyloidiasis;   Shigellosis;   Intestinal Salmonellosis;   Campylobacteriosis;   Aeromonas Spp. Infections;   Giardiasis;   Amoebiasis;   Dientamoebiasis;   Cryptosporidium Spp. Infections
Interventions: Procedure: Stool culturing for pathogenic bacteria;   Procedure: Kato-Katz technique;   Procedure: Baermann technique;   Device: Mini-FLOTAC;   Device: Crypto/Giardia Duo Strip;   Procedure: Formalin-ether concentration technique;   Device: CCA RDT;   Procedure: Koga agar plate culture;   Procedure: Kinyoun staining;   Device: Multiplex PCR;   Procedure: Metagenomics analysis
34 Recruiting Study of Benznidazole Transfer Into Breastmilk in Lactating Women With Chagas Disease
Conditions: Chagas Disease;   Lactation
Intervention:
35 Recruiting Collection of Biological Material From Pregnant Women in a Malarial Region
Condition: Malaria
Intervention:
36 Recruiting IMPROV (Improving the Radical Cure of Vivax Malaria)
Condition: Uncomplicated Vivax Malaria
Interventions: Drug: Primaquine;   Drug: Placebo
37 Recruiting Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa
Condition: Lymphatic Filariasis
Interventions: Drug: Diethylcarbamazine;   Drug: Albendazole;   Drug: Ivermectin
38 Unknown  Treatment of Iron Deficiency Anemia in Malaria Endemic Ghana
Condition: Anemia
Interventions: Dietary Supplement: Sprinkles®;   Dietary Supplement: vitamin/mineral fortificant without iron
39 Recruiting Study to Assess the Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects
Condition: Malaria
Interventions: Drug: ACT-451840;   Other: Plasmodium falciparum-infected human erythrocytes;   Drug: Artemether 20 mg and lumefantrine 120mg combination tablet;   Drug: Primaquine
40 Recruiting Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali
Condition: Malaria
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years